Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Qidu Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of intravenous infusions and injectable medications. Established in 1976 and headquartered in Zibo, Shandong, the company has grown into a large-scale enterprise with a diverse product portfolio covering anti-infectives, cardiovascular health, parenteral nutrition, and electrolyte balance. Qidu is a leader in the Chinese infusion market, utilizing advanced manufacturing technologies such as Blow-Fill-Seal (BFS) and non-PVC soft bag production lines to ensure high quality and safety. The company serves a vast network of healthcare providers in China and exports its products to international markets, maintaining a strong focus on generic drug consistency and therapeutic innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 齐都药业.